If a patient experienced dizziness that led to syncope AND continues to have dizziness after regaining consciousness, you can code: R55 (principal) for the syncope event R42 (secondary) for the ongoing dizziness Do not code both if the dizziness was only prodromal (leading up to the syncope) and resolved
They are not waiting for symptoms to become problems before addressing them
FDA staff's own briefing document, posted publicly ahead of the meeting as part of the docket, proposes that TB-500 (free base) and TB-500 acetate not be added to the list, citing incomplete physicochemical characterization, a lack of evidence of effectiveness for wound healing (including an in-vitro fibroblast study in which TB-500 reportedly did not induce wound healing), and insufficient nonclinical and clinical safety data
Drug-based treatments cannot raise the number of neuron cells, thus making most of the traditional treatment options ineffective
Neurotrophic factor modulation: Peptides like Semax and Dihexa directly influence brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and other proteins essential for neuron survival, growth, and synaptic plasticity
